Bellingan, G. http://orcid.org/0000-0003-4193-4689
Jacono, F.
Bannard-Smith, J.
Brealey, D.
Meyer, N.
Thickett, D.
Young, D.
Bentley, A.
McVerry, B. J.
Wunderink, R. G.
Doerschug, K. C.
Summers, C.
Rojas, M.
Ting, A. http://orcid.org/0000-0002-5058-9576
Jenkins, E. D.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance
https://doi.org/10.1136/thoraxjnl-2017-211439
Safety and efficacy of multipotent adult progenitor cells in acute respiratory distress syndrome (MUST-ARDS): a multicentre, randomised, double-blind, placebo-controlled phase 1/2 trial
https://doi.org/10.1007/s00134-021-06570-4
Where next for cell-based therapy in ARDS
https://doi.org/10.1136/thoraxjnl-2018-212272
Funding for this research was provided by:
National Institute on Alcohol Abuse and Alcoholism (R42AA024003)
Innovate UK (102165)
Article History
Received: 17 August 2021
Accepted: 28 October 2021
First Online: 23 November 2021
Declarations
:
: Two of the authors, EJ and AT, were employees of Athersys and one, GB, received a travel grant from Athersys to two meetings. No other Conflict of interest are declared